COM:EYEPOINTPHARMA
EyePoint Pharmaceuticals
- Stock
Last Close
8.96
21/11 21:00
Market Cap
452.61M
Beta: -
Volume Today
2.24M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -13.36M - | 6.35M 147.53% | -21.55M 439.48% | -18.48M 14.21% | -53.17M 187.64% | -56.79M 6.81% | -45.39M 20.07% | -58.42M 28.69% | -102.25M 75.04% | -70.80M 30.77% | |
depreciation and amortization | 917K - | 882K 3.82% | 908K 2.95% | 815K 10.24% | 1.15M 40.86% | 2.60M 126.83% | 2.65M 1.73% | 2.77M 4.61% | 2.45M 11.73% | 464K 81.03% | |
deferred income tax | -78K - | 26.28M - | 3.81M 85.50% | 905K 76.25% | -787K 186.96% | 83K - | |||||
stock based compensation | 1.41M - | 1.96M 38.98% | 2.16M 10.30% | 2.46M 13.55% | 2.70M 10.10% | 4.57M 68.93% | 5.55M 21.43% | 7.45M 34.25% | 14.18M 90.37% | 12.06M 14.95% | |
change in working capital | 389K - | 1.01M 159.38% | 2.07M 105.45% | 318K 84.66% | 925K 190.88% | -12.54M 1,455.24% | 20.14M 260.63% | -1.74M 108.64% | -3.02M 73.84% | 58.88M 2,047.80% | |
accounts receivables | 103K - | -124K 220.39% | 116K 193.55% | 219K 88.79% | 7K 96.80% | -15.30M 218,728.57% | 4.85M 131.66% | -10.60M 318.80% | -2.66M 74.89% | 14.43M 642.15% | |
inventory | 729K - | 917K 25.79% | 1.22M 33.37% | 551K 54.95% | -759K 237.75% | -1.86M 144.93% | -3.20M 72.14% | 1.35M 142.09% | -760K 156.42% | -1.55M 104.34% | |
accounts payables | -213K - | 292K 237.09% | 626K 114.38% | -346K 155.27% | 1.75M 604.91% | 4.60M 163.08% | 1.87M 59.27% | 8.48M 352.78% | 1.20M 85.87% | 1.52M 26.79% | |
other working capital | -230K - | -76K 66.96% | 108K 242.11% | -106K 198.15% | -70K 33.96% | 31K 144.29% | 16.62M 53,506.45% | -959K 105.77% | -799K 16.68% | 44.48M 5,667.46% | |
other non cash items | 45K - | 98K 117.78% | 87K 11.22% | -5.59M 6,529.89% | 209K 103.74% | 1.65M 688.52% | 1.72M 4.49% | 628K 63.53% | 23.65M 3,665.76% | 1.18M 94.99% | |
net cash provided by operating activities | -10.67M - | 10.30M 196.50% | -16.32M 258.45% | -20.49M 25.58% | -21.91M 6.92% | -56.70M 158.82% | -14.44M 74.54% | -50.10M 247.05% | -65.00M 29.76% | 1.88M 102.88% | |
investments in property plant and equipment | -248K - | -161K 35.08% | -113K 29.81% | -147K 30.09% | -108K 26.53% | -213K 97.22% | -362K 69.95% | -156K 56.91% | -2.15M 1,278.21% | -3.48M 62% | |
acquisitions net | 78K - | -16.78M - | -558K - | ||||||||
purchases of investments | -2.96M - | -10.22M 244.87% | -17.52M 71.37% | -5.05M 71.16% | -32.97M - | -139.12M 322.01% | -55.12M 60.38% | ||||
sales maturities of investments | 3.35M - | 3.65M 8.96% | 13.17M 260.77% | 18.74M 42.34% | 124M - | 55.28M 55.42% | |||||
other investing activites | -150K - | 33K - | 558K - | ||||||||
net cash used for investing activites | 66K - | -6.73M 10,301.52% | -4.46M 33.73% | 13.58M 404.28% | -16.89M 224.39% | -213K 98.74% | -362K 69.95% | -33.12M 9,049.45% | -17.27M 47.87% | -3.31M 80.80% | |
debt repayment | -20M - | -13.84M 30.79% | -146K 98.95% | -71.77M 49,058.90% | -40.51M 43.56% | ||||||
common stock issued | 18.06M - | 16.50M - | 8.40M 49.07% | 41.52M 393.99% | 22.63M 45.50% | 49.92M 120.61% | 216.82M 334.36% | 395K 99.82% | 229.55M 58,014.18% | ||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 987K - | 235K 76.19% | 490K 108.51% | 99K 79.80% | 19.16M 19,249.49% | 31.24M 63.07% | 1.42M 95.46% | 223K 84.26% | 70.69M 31,598.21% | -1.97M 102.79% | |
net cash used provided by financing activities | 19.04M - | 235K 98.77% | 16.99M 7,129.79% | 8.50M 49.95% | 60.67M 613.52% | 33.86M 44.18% | 37.49M 10.71% | 216.90M 478.53% | -690K 100.32% | 187.07M 27,211.59% | |
effect of forex changes on cash | -4K - | -12K 200% | -20K 66.67% | -5K 75% | 2K 140% | 1K 50% | |||||
net change in cash | 8.44M - | 3.79M 55.10% | -3.81M 200.55% | 1.58M 141.62% | 21.88M 1,280.32% | -23.05M 205.34% | 22.70M 198.47% | 133.68M 489.05% | -82.96M 162.06% | 185.63M 323.76% | |
cash at beginning of period | 6.90M - | 15.33M 122.26% | 19.12M 24.70% | 15.31M 19.92% | 17.05M 11.33% | 45.41M 166.37% | 22.36M 50.75% | 45.06M 101.48% | 178.74M 296.69% | 95.63M 46.50% | |
cash at end of period | 15.33M - | 19.12M 24.70% | 15.31M 19.92% | 16.90M 10.35% | 38.93M 130.36% | 22.36M 42.55% | 45.06M 101.48% | 178.74M 296.69% | 95.78M 46.41% | 281.26M 193.65% | |
operating cash flow | -10.67M - | 10.30M 196.50% | -16.32M 258.45% | -20.49M 25.58% | -21.91M 6.92% | -56.70M 158.82% | -14.44M 74.54% | -50.10M 247.05% | -65.00M 29.76% | 1.88M 102.88% | |
capital expenditure | -248K - | -161K 35.08% | -113K 29.81% | -147K 30.09% | -108K 26.53% | -213K 97.22% | -362K 69.95% | -156K 56.91% | -2.15M 1,278.21% | -3.48M 62% | |
free cash flow | -10.92M - | 10.14M 192.83% | -16.43M 262.09% | -20.64M 25.61% | -22.02M 6.68% | -56.91M 158.51% | -14.80M 74.00% | -50.25M 239.62% | -67.16M 33.63% | -1.61M 97.61% |
All numbers in (except ratios and percentages)